Physician profile
Sameera Imtiaz
NPI 1174047625
$512.47
in general payments reported to CMS, 2019-2025
14 companies · $39.02 in 2025
The $39.02 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.14 · 2022: $361 · 2023: $20.10 · 2024: $48.01 · 2025: $39.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $102.25 | 2022 | |
| Abbott Laboratories | $81.02 | 2022 | |
| Cranial Technologies, INC | $65.72 | 2024-2025 | Doc Band |
| Abbvie INC. | $51.71 | 2022 | |
| Lilly USA, LLC | $33.19 | 2022 | |
| Janssen Pharmaceuticals, INC | $23.31 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.52 | 2022 | |
| Hologic Sales and Service, LLC | $21.31 | 2025 | Aptima |
| Vivus LLC | $20.83 | 2021 | |
| Phadia US INC. | $20.10 | 2023 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.91 | 2022 | |
| Nestle Healthcare Nutrition INC. | $18.96 | 2022 | |
| Allergan, INC. | $16.80 | 2022 | |
| Merck Sharp & Dohme LLC | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameera Imtiaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.